429 related articles for article (PubMed ID: 24008082)
1. Formulation and in vitro/in vivo evaluation of levodopa transdermal delivery systems.
Lee KE; Choi YJ; Oh BR; Chun IK; Gwak HS
Int J Pharm; 2013 Nov; 456(2):432-6. PubMed ID: 24008082
[TBL] [Abstract][Full Text] [Related]
2. Formulation and evaluation of ubidecarenone transdermal delivery systems.
Jung SY; Kang EY; Choi YJ; Chun IK; Lee BK; Gwak HS
Drug Dev Ind Pharm; 2009 Sep; 35(9):1029-34. PubMed ID: 19365779
[TBL] [Abstract][Full Text] [Related]
3. Effects of vehicles on the percutaneous absorption of donepezil hydrochloride across the excised hairless mouse skin.
Kim KH; Gwak HS
Drug Dev Ind Pharm; 2011 Sep; 37(9):1125-30. PubMed ID: 21417615
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of formulated tenoxicam transdermal delivery systems.
Kim T; Kang E; Chun I; Gwak H
J Pharm Pharmacol; 2008 Jan; 60(1):135-8. PubMed ID: 18088513
[TBL] [Abstract][Full Text] [Related]
5. The effects of fatty acids in propylene glycol on the percutaneous absorption of alendronate across the excised hairless mouse skin.
Choi A; Gang H; Chun I; Gwak H
Int J Pharm; 2008 Jun; 357(1-2):126-31. PubMed ID: 18329198
[TBL] [Abstract][Full Text] [Related]
6. Effect of vehicles and enhancers on the in vitro permeation of melatonin through hairless mouse skin.
Gwak HS; Kim SU; Chun IK
Arch Pharm Res; 2002 Jun; 25(3):392-6. PubMed ID: 12135116
[TBL] [Abstract][Full Text] [Related]
7. Effects of amines on percutaneous absorption of alendronate.
Whang J; Gwak H
Drug Dev Ind Pharm; 2011 May; 37(5):491-7. PubMed ID: 21126206
[TBL] [Abstract][Full Text] [Related]
8. Effect of fatty acids on the transdermal delivery of donepezil: in vitro and in vivo evaluation.
Choi J; Choi MK; Chong S; Chung SJ; Shim CK; Kim DD
Int J Pharm; 2012 Jan; 422(1-2):83-90. PubMed ID: 22037444
[TBL] [Abstract][Full Text] [Related]
9. Effect of permeation enhancers on transdermal delivery of fluoxetine: in vitro and in vivo evaluation.
Jung E; Kang YP; Yoon IS; Kim JS; Kwon SW; Chung SJ; Shim CK; Kim DD
Int J Pharm; 2013 Nov; 456(2):362-9. PubMed ID: 24012861
[TBL] [Abstract][Full Text] [Related]
10. Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin.
Gwak HS; Chun IK
Int J Pharm; 2002 Apr; 236(1-2):57-64. PubMed ID: 11891070
[TBL] [Abstract][Full Text] [Related]
11. Transdermal delivery of ketorolac tromethamine: effects of vehicles and penetration enhancers.
Cho YA; Gwak HS
Drug Dev Ind Pharm; 2004 Jul; 30(6):557-64. PubMed ID: 15285328
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
Yang Z; Teng Y; Wang H; Hou H
Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
[TBL] [Abstract][Full Text] [Related]
13. In vitro percutaneous absorption of ondansetron hydrochloride from pressure-sensitive adhesive matrices through hairless mouse skin.
Gwak HS; Oh IS; Chun IK
Arch Pharm Res; 2003 Aug; 26(8):644-8. PubMed ID: 12967200
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic characteristics of formulated alendronate transdermal delivery systems in rats and humans.
Choi A; Gang H; Whang J; Gwak H
Drug Deliv; 2010 May; 17(4):249-54. PubMed ID: 20214414
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic evaluation and modeling of formulated levodopa intranasal delivery systems.
Kim TK; Kang W; Chun IK; Oh SY; Lee YH; Gwak HS
Eur J Pharm Sci; 2009 Dec; 38(5):525-32. PubMed ID: 19804823
[TBL] [Abstract][Full Text] [Related]
16. The effect of vehicles and pressure sensitive adhesives on the percutaneous absorption of quercetin through the hairless mouse skin.
Kim HW; Gwak HS; Chun IK
Arch Pharm Res; 2004 Jul; 27(7):763-8. PubMed ID: 15357005
[TBL] [Abstract][Full Text] [Related]
17. Development of matrix patches for transdermal delivery of a highly lipophilic antiestrogen.
Funke AP; Günther C; Müller RH; Lipp R
Drug Dev Ind Pharm; 2003 Aug; 29(7):785-93. PubMed ID: 12906336
[TBL] [Abstract][Full Text] [Related]
18. Application of hydrotropy to transdermal formulations: hydrotropic solubilization of polyol fatty acid monoesters in water and enhancement effect on skin permeation of 5-FU.
Takahashi K; Komai M; Kinoshita N; Nakamura E; Hou XL; Takatani-Nakase T; Kawase M
J Pharm Pharmacol; 2011 Aug; 63(8):1008-14. PubMed ID: 21718283
[TBL] [Abstract][Full Text] [Related]
19. Transdermal delivery of ondansetron hydrochloride: effects of vehicles and penetration enhancers.
Gwak HS; Oh IS; Chun IK
Drug Dev Ind Pharm; 2004 Feb; 30(2):187-94. PubMed ID: 15089053
[TBL] [Abstract][Full Text] [Related]
20. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
Aboofazeli R; Zia H; Needham TE
Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
